Found 13 matching trials
Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction
PHASE3This study is to assess LDL-C reductions at Week 52 with monthly (Q4W \[≤31...
Location
Sterling Research Group
Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients
PHASE3Comparison of LDL-C reductions of lerodalcibep (LIB003) 300 mg to inclisira...
Location
CHU de Nantes - Hôpital Nord Laennec
Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH
PHASE3To compare the safety, tolerability and LDL-C response after 24 Weeks of mo...
Location
NorthShore University Health System
Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003
PHASE2To assess the longer term safety, tolerability, and LDL C lowering efficacy...
Location
Sterling Research Group
Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction
PHASE3This study is to assess LDL-C reductions at Week 24 and the mean of Weeks 2...
Location
Metabolic & Atherosclerosis Research Center (MARC)
Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients
PHASE3Comparison of LDL-C reductions at Week 12 of monthly (Q4W\[≤ 31 days\]) dos...
Location
Sterling Research Group
Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH
PHASE3The goal of this clinical trial is to assess the LDL-Cholesterol reductions...
Status
Enrolling By Invitation
Location
Metabolic & Atherosclerosis Research Center
A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants
PHASE1This is a single-center, randomized, double-blind, placebo-controlled, sing...
Status
Enrolling By Invitation
Location
West China Hospital of Sichuan University
Long-Term Efficacy and Safety of Lerodalcibep in Children and Adolescents With Familial Hypercholesterolemia
PHASE3The goal is to assess the long term efficacy (LDL cholesterol reduction) an...
Location
G.B. Pant Institute of Postgraduate Medical Education & Research
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
PHASE3This randomized study is to assess LDL-C reductions at Week 12 with monthly...
Location
Beijing Anzhen Hospital of Capital Medical University